CervoMed Reports Last Patient Last Visit in Phase 2b RewinD-LB Trial

TipRanksOct 15 08:06 ET

Express News | CervoMed Announces Last Patient Last Visit in Phase 2B Rewind-Lb Trial of Neflamapimod for the Treatment of Early-Stage Dementia With Lewy Bodies (Dlb)

ReutersOct 15 08:00 ET

CervoMed Announces Last Patient Last Visit in Phase 2b RewinD-LB Trial of Neflamapimod for the Treatment of Early-Stage Dementia With Lewy Bodies (DLB)

GlobeNewswireOct 15 08:00 ET

Express News | CervoMed Inc Files for Mixed Shelf Offering of $250 Mln-SEC Filing

ReutersOct 3 17:14 ET

Express News | CervoMed Inc: Not Subject to Any Termination Penalties or Other Expenses Related to Termination of Sales Agreement

ReutersOct 3 16:23 ET

Express News | CervoMed Inc: Notified Btig, LLC That Co Is Terminating Sales Agreement, Effective October 11

ReutersOct 3 16:23 ET